Connect Biopharma Holdings Limited (CNTB)

CNTB Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Net Income	-64.61	-55.48	-15.63	-62.11	-118.09	-202.27
Depreciation & Amortization	0.7	0.7	0.66	0.72	1.03	0.63
Loss (Gain) From Sale of Assets	0	0.04	0.01	0.1	-	0.04
Asset Writedown & Restructuring Costs	-	-	0.23	-	4.7	-
Loss (Gain) From Sale of Investments	-0.53	-0.77	-0.12	-1.7	-	-
Stock-Based Compensation	3.98	3.73	6.73	5.4	6.91	8.99
Other Operating Activities	-	-	-	-	-2.52	104.7
Change in Accounts Receivable	0.01	0.78	-0.79	-	4.05	-2.31
Change in Accounts Payable	3.49	1.62	-1.87	-1.14	-0.78	8.97
Change in Unearned Revenue	-0.16	0	-13.16	13.32	-	-
Change in Other Net Operating Assets	-0.13	-1.82	0.32	-2.33	3.19	-3.08
Operating Cash Flow	-57.25	-51.21	-23.61	-47.74	-101.52	-84.32
Capital Expenditures	-0.35	-0.43	-0.75	-0.08	-4.41	-3.83
Sale of Property, Plant & Equipment	-	0	-	0	-	-
Sale (Purchase) of Intangibles	-	-	-	2.94	-	-0.05
Investment in Securities	36.81	10.25	-2.7	72.12	-81.84	2.12
Other Investing Activities	-	-	-	-	-	-3.44
Investing Cash Flow	36.46	9.82	-3.45	74.98	-86.24	-5.21
Long-Term Debt Repaid	-	-	-	-	-0.22	-0.13
Net Debt Issued (Repaid)	-	-	-	-	-0.22	-0.13
Issuance of Common Stock	18.71	1.09	0.23	0.05	0.14	220.02
Repurchase of Common Stock	-	-	-	-	-	-0.57
Other Financing Activities	-	-	-	-	-	-17.11
Financing Cash Flow	18.71	1.09	0.23	0.05	-0.09	202.22
Foreign Exchange Rate Adjustments	0.41	0.41	-0.6	-0.57	-0.86	0.22
Net Cash Flow	-1.68	-39.89	-27.43	26.72	-188.71	112.91
Free Cash Flow	-57.61	-51.64	-24.36	-47.82	-105.93	-88.16
Free Cash Flow Margin	-24723.18%	-80687.50%	-93.58%	-	-	-
Free Cash Flow Per Share	-1.03	-0.93	-0.44	-0.87	-1.92	-1.69
Cash Income Tax Paid	0.29	0.29	0.11	0.12	-	-
Levered Free Cash Flow	-34.13	-30.65	-21.1	-25.55	-67.55	-46.03
Unlevered Free Cash Flow	-34.13	-30.65	-21.1	-25.55	-67.54	-46.02
Change in Working Capital	3.2	0.58	-15.49	9.85	6.46	3.58

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q